Cargando…
Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis– A Phase Ib Clinical Trial
BACKGROUND: Sepsis has no proven specific pharmacologic treatment and reported mortality ranges from 30%–45%. The primary aim of this phase IB study was to determine the safety profile of Allocetra™-OTS (early apoptotic cell) infusion in subjects presenting to the emergency room with sepsis. The sec...
Autores principales: | van Heerden, Peter Vernon, Abutbul, Avraham, Sviri, Sigal, Zlotnick, Eitan, Nama, Ahmad, Zimro, Sebastian, el-Amore, Raja, Shabat, Yehudit, Reicher, Barak, Falah, Batla, Mevorach, Dror |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515139/ https://www.ncbi.nlm.nih.gov/pubmed/34659208 http://dx.doi.org/10.3389/fimmu.2021.718191 |
Ejemplares similares
-
Apoptotic cell therapy for cytokine storm associated with acute severe sepsis
por: Karbian, Netanel, et al.
Publicado: (2020) -
Apoptotic cells for treatment of acute respiratory distress syndrome associated with COVID-19
por: van Heerden, Peter Vernon, et al.
Publicado: (2023) -
Comment on: Rethinking ICU readmission and timelimited trial in the contingency capacity
por: Beil, Michael, et al.
Publicado: (2022) -
Ethical considerations about artificial intelligence for prognostication in intensive care
por: Beil, Michael, et al.
Publicado: (2019) -
Apoptotic Cells Induced Signaling for Immune Homeostasis in Macrophages and Dendritic Cells
por: Trahtemberg, Uriel, et al.
Publicado: (2017)